Spontaneous, complete recovery to normal thyroid function may occur in ≥90% of patients.[2]Fatourechi V, Aniszewski JP, Fatourechi GZ, et al. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted county, Minnesota, study. J Clin Endocrinol Metab. 2003 May;88(5):2100-5.
http://www.ncbi.nlm.nih.gov/pubmed/12727961?tool=bestpractice.com
However, the thyroid gland may exhibit irregular scarring between islands of residual functioning parenchyma.
Approximately 15% of patients will have permanent hypothyroidism and require lifelong levothyroxine to normalise the thyroid-stimulating hormone.[2]Fatourechi V, Aniszewski JP, Fatourechi GZ, et al. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted county, Minnesota, study. J Clin Endocrinol Metab. 2003 May;88(5):2100-5.
http://www.ncbi.nlm.nih.gov/pubmed/12727961?tool=bestpractice.com
[4]Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343-421.
https://www.liebertpub.com/doi/10.1089/thy.2016.0229
http://www.ncbi.nlm.nih.gov/pubmed/27521067?tool=bestpractice.com
Specific human leukocyte antigen alleles appear to be associated with increased risk for recurrence.[59]Stasiak M, Tymoniuk B, Stasiak B, et al. The risk of recurrence of subacute thyroiditis Is HLA-dependent. Int J Mol Sci. 2019 Mar 3;20(5):1089.
https://www.doi.org/10.3390/ijms20051089
http://www.ncbi.nlm.nih.gov/pubmed/30832406?tool=bestpractice.com